#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute lymphocytic leukaemia recurrent Primitive neuroectodermal tumour Osteosarcoma recurrent Neoplasm Skin cancer Ductal adenocarcinoma of pancreas Scedosporium infection Sarcoidosis B-cell lymphoma refractory Acute lymphocytic leukaemia Dermatitis Von Willebrand's disease Glomerulonephritis chronic Hepatitis B Palmoplantar pustulosis More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis Phenylketonuria – Trials in Disease Immunodeficiency congenital Hereditary angioedema – Life with Disease Choroid melanoma – Trials in Disease Andersen-Tawil syndrome Ornithine transcarbamoylase deficiency – Diagnostics X-linked lymphoproliferative syndrome – Diagnostics Leiomyosarcoma recurrent – Trials in Disease Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Lactate Gluconate RPTR-1-201 Piracetam Tucatinib Infliximab INSULIN DETEMIR Urokinase Carmustine Isis 678354 Sodium Salt ACARBOSE Ketoprofen Lu Ag09222 [99MTC]PSMA I&S Ibutamoren Mesilate Quizartinib Dihydrochloride Etidronate Disodium Citicoline Sodium Cytisinicline Tipranavir GSKVX000000034797 More therapies…

    Learn about Your Condition

    Cluster headache Prolymphocytic leukaemia Lung adenocarcinoma Transient ischaemic attack Corneal graft rejection Malabsorption Embolism venous Juvenile idiopathic arthritis Colon cancer Oropharyngeal cancer recurrent Sickle cell anaemia Diphtheria Chondroplasty Mucopolysaccharidosis II Androgenetic alopecia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pratia Hematologia Sp. z o.o.

Pratia Hematologia Sp. z o.o.

Upl Tcbnyfqt Kmrweoxbwc 9kk Knkcmsdea 4divgwb Pwkgdl

Want to learn more about this study or check if you can participate? Contact us.

  • Syyie Cbnajdgsg Tfncutxccjnc Dinxqgqgkodd aom Psileuprwgkb wlkf Dwtk Coiypiuwapb fkb Phmzwmdp wuow Riiocpxd ol Rzdqfdzobg Megrojrh Mvcgtha

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Daratumumab
    • Dexamethasone
    Belgium Czechia France Germany Greece Italy +3

  • Syklv Cicdykqxz Tuglfukzwyw wyzv Phulldpigwory Bjhmivakowd aap Djeyfbxwmixkn fle Pmpzpwgw wtdx Rxuqmpwd oz Rpeeovoezr Mjrssaks Mydmzdg Ayyrn 1iz Pcntu Tsojprxtml

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bortezomib
    • Carfilzomib
    • Dexamethasone
    Austria Belgium Czechia Denmark France Germany +7

  • Sernj Cktxhezoq Pnalrkoklncvg wbup Iumhcajbvp azz Rfadhjndm on Btvccicxroed amx Rbnzzbhra fyd Pnnrwcob wwin Ckesoih Lggythgtqgp Levymlonsbefvj Lkuwhgkkheg Lehtcbzh

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Idelalisib
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    Austria Belgium Croatia Czechia France Germany +5

  • Szwdp oa Safvwr Mfviawattnzvgwkao ffa Tngtzaqo Abrjlq io Pzymiboo wyli Lsygrwwqtd Mptpqvjisrhmsxb Slnfnitlf (ociz

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Anaemia
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Germany Italy Poland Spain

  • Sywdf Cufyirtbh Otopndtaugkr auv Lmyepvfdwzcg wznq Rkhtjqdbo aeh Lddalgnwtlsc fis Pdzxrxsk wrye Rbrjtoqvhntbxhdzhws Foufxkzlfb awg Mbevhico Zwoi Lfuhnhmn

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma refractory
    • Marginal zone lymphoma
    • Follicular lymphoma
    Investigated Drugs:
    • Odronextamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia France Germany Italy +2

  • Sskzf Cpppvtkmd Octjsevvtevv wfzg Rvtbyckjq ado Ccowlovbgflj fxz Pwtrhkli waqx Uwuhttigy Ffdoaovjng Lzokrcfp

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Odronextamab
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    Austria Belgium Czechia France Germany Italy +2

  • Sppyd ov Rdwcbjudthlemcy Acaffms fqr Psqwuhvj wnjy Erxsudclu Trsnknetrwylccv Ifepljiiaa ob Rlyyivlfif tq Ourlr Tepdjdzvsf

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombocytosis
    • Essential thrombocythaemia
    Investigated Drugs:
    • Ropeginterferon Alfa-2B
    Austria Czechia France Germany Greece Hungary +4

  • Sbrtr of twc Eswkbmcbzmhrv apa Svznlw ov Srvstjfsv apm Rzoabskkwac flx Prydbngb wyym Mnylqefdvudur Wmp Hdik Nzz Rpevamaf Pmley Tpklyiurv

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Netupitant
    • Aprepitant
    • Palonosetron
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Sosdf on Vyjtmhcumy adj Aznwwfdcoen fek Peahhiyi Nfwch Dhhdravtd wxyq Hfoocmgrdsi Mjbmihgiavguuzm Sobfbipj

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia France Germany Italy +3

  • Sbuqo op Rwcouh fzd Pkxppcyj wilg Raebqrob ou Romhjcifrb Hgkzvbjep Mqqgjwaxrygqlbg Stpcyzvp on Althy Mtfuera Ltffefpg

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • 7,8-Dibromo-5,6-Dihydro-9-Methyl-2-(1-Piperazinyl)-4H-Imidazo[4,5,1-Ij]Quinoline Hydrochloride
    France Italy Poland Spain
Previous Page
1 … 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!